Table 1 Patient characteristics (n = 93).

From: Association of PD-L1 expression by immunohistochemistry and gene microarray with molecular subtypes of ovarian tumors

Characteristic

No. of patients (%)

Tumor proportion score (TPS)

  0

16 (17.2)

  ≥1%

77 (82.8)

  ≥10%

11 (11.8)

Combined positive score (CPS)

  0

3 (3.2)

  ≥1

90 (96.8)

  ≥10

22 (23.7)

Molecular subtype

  Differentiated

27 (29.0)

  Immunoreactive

18 (19.4)

  Mesenchymal

27 (29.0)

  Proliferative

21 (22.6)

Histological subtype

  Serous

80 (86.0)

  Endometrioid

5 (5.4)

  Clear cell

1 (1.1)

  Mixed

3 (3.2)

  Other

4 (4.3)

Histological grade

  Low

25 (26.9)

  High

64 (68.8)

  Unknown

4 (4.3)

Primary site

  Ovarian

82 (88.2)

  Fallopian tube

6 (6.5)

  Primary peritoneal

4 (4.3)

  Unknown

1 (1.1)

Stage

  IIIA/IIIB

8 (8.6)

  IIIC

77 (82.8)

  IV

8 (8.6)

Elevated CA-125

  Yes

82 (88.2)

  No

11 (11.8)

Residual disease

  No or microscopic

67 (72.0)

  <1 cm

26 (28.0)

  1. Clinical, immunohistopathologic, and molecular characteristics of 93 ovarian tumors.